CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 420 filers reported holding CRISPR THERAPEUTICS AG in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388,356 | -12.5% | 8,556 | +8.2% | 0.12% | -7.5% |
| Q2 2023 | $443,842 | +24.9% | 7,906 | +0.6% | 0.13% | +18.8% |
| Q1 2023 | $355,326 | +14.2% | 7,856 | +2.6% | 0.11% | +3.7% |
| Q4 2022 | $311,216 | -40.6% | 7,656 | -4.5% | 0.11% | -41.9% |
| Q3 2022 | $524,000 | -2.4% | 8,020 | -9.3% | 0.19% | +0.5% |
| Q2 2022 | $537,000 | -13.5% | 8,840 | -10.6% | 0.18% | 0.0% |
| Q1 2022 | $621,000 | -24.7% | 9,890 | -9.2% | 0.18% | -11.9% |
| Q4 2021 | $825,000 | -34.0% | 10,890 | -2.5% | 0.21% | -30.7% |
| Q3 2021 | $1,250,000 | -30.1% | 11,170 | +1.1% | 0.30% | -24.8% |
| Q2 2021 | $1,788,000 | +44.3% | 11,045 | +8.6% | 0.40% | +18.5% |
| Q1 2021 | $1,239,000 | -9.8% | 10,170 | +13.4% | 0.34% | -17.3% |
| Q4 2020 | $1,373,000 | +73.8% | 8,970 | -5.0% | 0.41% | +37.9% |
| Q3 2020 | $790,000 | +18.4% | 9,445 | +4.1% | 0.30% | +15.1% |
| Q2 2020 | $667,000 | +73.7% | 9,075 | +0.3% | 0.26% | +41.5% |
| Q1 2020 | $384,000 | -6.1% | 9,045 | +34.6% | 0.18% | +10.2% |
| Q4 2019 | $409,000 | +752.1% | 6,720 | +397.8% | 0.17% | +690.5% |
| Q1 2019 | $48,000 | +242.9% | 1,350 | +170.0% | 0.02% | +110.0% |
| Q4 2018 | $14,000 | -36.4% | 500 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $22,000 | -42.1% | 500 | -23.1% | 0.01% | -42.9% |
| Q2 2018 | $38,000 | +442.9% | 650 | +52.9% | 0.01% | +366.7% |
| Q2 2017 | $7,000 | -22.2% | 425 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $9,000 | +28.6% | 425 | +30.8% | 0.01% | +25.0% |
| Q4 2016 | $7,000 | – | 325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |